Award
Purchase Order #75F40126P00293
Purchase Order for Semi-Automatic Aerosol Filler to FDA's CDER
Buyer
Food and Drug Administration
Award Amount
$210,424.71
Ceiling
$210,424.71
Awarded
September 08, 2026
Period of Performance
Sep 08, 2026 – Sep 07, 2027
Identifier
75F40126P00293
NAICS
339113
This award represents a purchase order contract to provide the Center for Drug Evaluation and Research (CDER), specifically its Office of Testing and Research (OTR), with a semi-automatic aerosol propellant filler designed for pMDI two-stage formulation processes. The recipient, Aantilia LLC, is engaged to deliver, install, and support the equipment, including validation, training, and warranty services. This specialized instrument is significant for advancing the agency's testing capabilities related to drug product formulations, ensuring quality and efficiency in aerosol medication production. The scope covers the full lifecycle from purchase through installation and operational readiness support, highlighting a comprehensive service approach. The contract was awarded through a competitive process based on the purchase order method to meet the agency's urgent specialized equipment needs. The performance period spans approximately one year, indicating a focused timeline for delivery and operational integration at the Silver Spring, Maryland facility. No additional subcontractors or acquisition programs are indicated for this contract.
Description
THE CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF TESTING AND RESEARCH (OTR), REQUIRES THE PURCHASE, DELIVERY, INSTALLATION, VALIDATION SUPPORT, TRAINING, AND WARRANTY OF A SEMIAUTOMATIC AEROSOL PROPELLANT FILLER FOR PMDI TWO-STAGE FORMUL